TY  - JOUR
AB  - This case is designed as an introductory exercise to familiarize students with several methods used to value early-stage companies. The value of a young biotech company is compared under the venture capital (VC), discounted cash flow (DCF), and real option methods of valuation. Students are asked to value the firm under the VC and DCF methods and then compare those values to the value obtained under the real option method. It is suggested that the student spreadsheet (UVA-F-1584X) be assigned in advance of the class with instructions to have students value the firm under the VC and DCF methods. A separate worksheet in the file (which can be hidden at the instructor's discretion) provides the option valuation for later discussion purposes. A technical note, “Valuing the Early-Stage Company” (UVA-F-1471), covering the basics of the VC and DCF methods of valuation can be assigned with the case.
VL  - 
IS  - 
SN  - 2474-7890
DO  - 10.1108/case.darden.2016.000163
UR  - https://doi.org/10.1108/case.darden.2016.000163
AU  - Chaplinsky Susan
PY  - 2017
Y1  - 2017/01/01
TI  - In-Fusion, Inc.
T2  - Darden Business Publishing Cases
PB  - University of Virginia Darden School Foundation
SP  - 1
EP  - 4
Y2  - 2024/05/06
ER  -